The neural basis of the complex mental task of meditation: Neurotransmitter and neurochemical considerations

Medical Hypotheses

Volumn 61, Issue 2, 2003, Pages 282-291

  Newberg, Andrew B ^a   Iversen, J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; NEUROTRANSMITTER;

AFFECT; AUTONOMIC NERVOUS SYSTEM; COGNITION; HUMAN; IMAGING; MEDITATION; MENTAL DISEASE; MENTAL FUNCTION; MENTAL TASK; MODEL; NEUROPHYSIOLOGY; PERCEPTION; PHYSICAL DISEASE; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 0042623446     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00175-0     Document Type: Article

References (78)

1. Herzog H., Lele V. R., Kuwert T. et al. Changed pattern of regional glucose metabolism during Yoga meditative relaxation. Neuropsychobiology 1990-1991; 23: 182-187.
2. Lou H. C., Kjaer T. W., Friberg L. et al. A 150-H20 PET study of meditation and the resting state of normal consciousness. Human Brain Map 1999; 7: 98-105.
3. Kjaer, Bertelsen, Piccini, Brooks, Alving, Lou, 2002.
4. Newberg A. B., Alavi A., Baime M. et al. The measurement of regional cerebral blood flow during the complex cognitive task of meditation: a preliminary SPECT study. Psychiatr Res Neuroimaging 2001; 106: 113-122.
5. Lazar S. W., Bush G., Gollub R. L. et al. Functional brain mapping of the relaxation response and meditation. Neuroreport 2000; 11: 1581-1585.
6. d'Aquili E. G., Newberg A. B. Religious and mystical states: a neuropsychological model. Zygon 1993; 28: 177-200.
7. Ingvar D. H. The will of the brain: cerebral correlates of willful acts. J Theor Biol 1994; 171: 7-12.
8. Frith C. D., Friston K., Liddle P. F. et al. Willed action and the prefrontal cortex in man. A study with PET. Proc R Soc Lond 1991; 244: 241-246.
9. Posner M. I., Petersen S. E. The attention system of the human brain. Ann Rev Neurosci 1990; 13: 25-42.
10. Pardo J. V., Fox P. T., Raichle M. E. Localization of a human system for sustained attention by positron emission tomography. Nature 1991; 349: 61-64.
11. Vogt B. A., Finch D. M., Olson C. R. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex 1992; 2: 435-443.
12. Crosson B., Sadek J. R., Maron L. et al. Relative shift in activity from medial to lateral frontal cortex during internally versus externally guided word generation. J Cognitive Neurosci 2001; 13: 272-283.
13. Cornwall J., Phillipson O. T. Mediodorsal and reticular thalamic nuclei receive collateral axons from prefrontal cortex and laterodorsal tegmental nucleus in the rat. NeurosciLett 1988; 88: 121-126.
14. Portas C. M., Rees G., Howseman A. M. et al. A specific role for the thalamus in mediating the interaction attention and arousal in humans. J Neurosci 1998; 18: 8979-8989.
15. Cheramy A., Romo R., Glowinski Role of corticostriatal glutamatergic neurons in the presynaptic control of dopamine release. In: M. Sandler, C. Feuerstein, B. Scatton et al., (eds). Neurotransmitter Interactions in the Basal Ganglia. New York: Raven Press, 1987.
16. Armony J. L., LeDoux J. E. In: M. S. Gazzaniga (ed). The New Cognitive Neurosciences. Cambridge: MIT Press, 2000.
17. Andrews T. J., Halpern S. D., Purves D. Correlated size variations in human visual cortex, lateral geniculate nucleus, and optic tract. J Neurosci 1997; 17: 2859-2868.
18. Bucci D. J., CoNey M., Gallagher M. Thalamic and basal forebrain cholinergic connections of the rat posterior parietal cortex. Neuroreport 1999; 10: 941-945.
19. Destexhe A., Contreras D., Steriade M. Mechanisms underlying the synchronizing action of corticothalamic feedback through inhibition of thalamic relay cells. J Neurophysiol 1998; 79: 999-1016.
20. Elias A. N., Guich S., Wilson A. F. Ketosis with enhanced GABAergic tone promotes physiological changes in transcendental meditation. Med Hypotheses 2000; 54: 660-662.
21. Adair K. C., Gilmore R. L., Fennell E. B. et al. Anosognosia during intracarotid barbiturate anaesthesia: unawareness or amnesia for weakness. Neurology 1995; 45: 241-243.
22. Fernandez-Duque D., Posner M. I. Brain imaging of attentional networks in normal and pathological states. J Clin Exp Neuropsychol 2001; 23: 74-93.
23. Stemmetz M. A., Motter B. C., Duffy C. J., Mountcastle V. B. Functional properties of parietal visual neurons: radial organization of directionalities within the visual field. J Neurosci 1987; 7: 177-191.
24. Lynch J. C. The functional organization of posterior parietal association cortex. Behav Brain Sci 1980; 3: 485-499.
25. Karnath H. O., Ferber S., Himmelbach M. Spatial awareness is a function of the temporal not the posterior parietal lobe. Nature 2001; 411: 950-953.
26. Fish D. R., Gloor P., Quesney F. L. et al. Clinical responses to electrical brain stimulation of the temporal and frontal lobes in patients with epilepsy. Brain 1993; 116: 397-414.
27. Saver J. L., Rabin J. The neural substrates of religious experience. J Neuropsychiatr Clin Neurosci 1997; 9: 498-510.
28. Joseph R. Neuropsychology, Neuropsychiatry, and Behavioral Neurology. New York: Williams & Wilkins, 1996: 197.
29. Redding F. K. Modification of sensory cortical evoked potentials by hippocampal stimulation. Electroencephalograph Clin Neurophysiol 1967; 22: 74-83.
30. Newman J., Grace A. A. Binding across time: the selective gating of frontal and hippocampal systems modulating working memory and attentional states. Conscious Cogn 1999; 8: 196-212.
31. Chow T. W., Cummings J. L. In: B. L. Miller, J. L. Cummings (eds). The Human Frontal Lobes. New York: Guilford Press, 1999.
32. Poletti C. E., Sujatanond M. Evidence for a second hippocampal efferent pathway to hypothalamus and basal forebrain comparable to fornix system: a unit study in the monkey. J Neurophysiol 1980; 44: 514-531.
33. Davis M. The role of the amygdala in fear and anxiety. Ann Rev Neurosci 1992; 15: 353-375.
34. Jevning R., Wallace R. K., Beidebach M. The physiology of meditation: a review. A wakeful hypometabolic integrated response. Neurosci Biobehav Rev 1992; 16: 415-424.
35. Foote S. Extrathalamic modulation of cortical function. Ann Rev Neurosci 1987; 10: 67-95.
36. Waterhouse B. D., Moises H. C., Woodward D. J. Phasic activation of the locus coemleus enhances responses of primary sensory cortical neurons to peripheral receptive field stimulation. Brain Res 1998; 790: 33-44.
37. Van Bockstaele E. J., Aston-Jones G. Integration in the ventral medulla and coordination of sympathetic, pain and arousal functions. Clin Exp Hypertens 1995; 17: 153-165.
38. Walton K. G., Pugh N. D., Gelderloos P., Macrae P. Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism. J Altern Complement Med 1995; 1: 263-283.
39. Infante J. R., Torres-Avisbal M., Pinel P. et al. Catecholamine levels in practitioners of the transcendental meditation technique. Physiol Behav 2001; 72: 141-146.
40. Ziegler D. R., Cass W. A., Herman J. P. Excitatory influence of the locus coemleus in hypothalamic-pituitary-adrenocortical axis responses to stress. J Neuroendocrinol 1999; 11: 361-369.
41. Livesey J. H., Evans M. J., Mulligan R., Donald R. A. Interactions of CRH, AVP and cortisol in the secretion of ACTH from perifused equine anterior pituitary cells: 'permissive' roles for cortisol and CRH. Endocr Res 2000; 26: 445-463.
42. Davies E., Keyon C. J., Fraser R. The role of calcium ions in the mechanism of ACTH stimulation of cortisol synthesis. Steroids 1985; 45: 551-560.
43. Sudsuang R., Chentanez V., Veluvan K. Effects of Buddhist meditation on serum cortisol and total protein levels, blood pressure, pulse rate, lung volume an reaction time. Physiol Behav 1991; 50: 543-548.
44. Jevning R., Wilson A. F., Davidson J. M. Adrenocortical activity during meditation. Horm Behav 1978; 10: 54-60.
45. Renand L. P. CNS pathways mediating cardiovascular regulation of vasopressin. Clin Exp Pharmacol Physiol 1996; 23: 157-160.
46. Pietrowsky R., Braun D., Fehm H. L., Pauschinger P., Born J. Vasopressin and oxytocin do not influence early sensory processing but affect mood and activation in man. Peptides 1991; 12: 1385-1391.
47. Weingartner H., Gold P., Ballenger J. C. et al. Effects of vasopressin on human memory functions. Science 1981; 211: 601-603.
48. O'Halloran J. P., Jevning R., Wilson A. F., Skowsky R., Walsh R. N., Alexander C. Hormonal control in a state of decreased activation: potentiation of arginine vasopressin secretion. Physiol Behav 1985; 35: 591-595.
49. Kiss J., Kocsis K., Csaki A., Gorcs T. J., Halasz B. Metabotropic glutamate receptor in GHRH and β-endorphin neurons of the hypothalamic arcuate nucleus. Neuroreport 1997; 8: 3703-3707.
50. Yadid G., Zangen A., Herzberg U., Nakash R., Sagen J. Alterations in endogenous brain beta-endorphin release by adrenal medullary transplants in the spinal cord. Neuropsychopharmacology 2000; 23: 709-716.
51. Janal M., Colt E., Clark W. et al. Pain sensitivity, mood and plasma endocrine levels in man following long-distance nmning: effects of naxalone. Pain 1984; 19: 13-25.
52. Infante J. R., Peran F., Martinez M. et al. ACTH and endorphin in transcendental meditation. Physiol Behav 1998; 64: 311-315.
53. Sim M. K, Tsoi W. F. The effects of centrally acting drugs on the EEG correlates of meditation. Biofeedback Self Regul 1992; 17: 215-220.
54. Albin R., Greenamyre J. Alternative excitotoxic hypotheses. Neurology 1992; 42: 733-738.
55. Thomas A. G., Vornov J. J., Olkowski J. L., Merion A. T., Slusher B. S. N-acetylated α-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin. J Pharmacol Exp Ther 2000; 295: 16-22.
56. Jevtovic-Todorovic V., Wozniak D. F., Benshoff N. D., Olney J. W. A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide. Brain Res 2001; 895: 264-267.
57. Vollenweider F. X., Leenders K. L., Scharfetter C. et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol 1997; 7: 9-24.
58. Gellhorn E., Kiely W. F. Mystical states of consciousness: neurophysiological and clinical aspects. J Nerv Mental Dis 1972; 154: 399-405.
59. Travis F. Autonomic and EEG patterns distinguish transcending from other experiences during transcendental meditation practice. Int J Psychophysiol 2001; 42: 1-9.
60. Peng C. K., Mietus J. E., Liu Y. et al. Exaggerates heart rate oscillations during two meditation techniques. Intern J Cardiol 1999; 70: 101-107.
61. Hugdahl K. Cognitive influences on human autonomic nervous system function. Curr Opin Neurobiol 1996; 6: 252-258.
62. Olds M. E., Forbes J. L. The central basis of motivation, intracranial self-stimulation studies. Ann Rev Psychol 1981; 32: 523-574.
63. Aghajanian G., Sprouse J., Rasmussen K. In: H. Meltzer (ed). Psychopharmacology, The Third Generation of Progress. New York: Raven Press, 1987.
64. Juckel G. J., Mendlin A., Jacobs B. L. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression. Neuropsychopharmacology 1999; 21: 391-398.
65. Van Praag H., De Haan S. Depression vulnerability and 5-hydroxytryptophan prophylaxis. Psychiatr Res 1980; 3: 75-83.
66. Aghajanian G. K., Marek G. J. Serotonin and hallucinogens. Neuropsychopharmacology 1999; 21: 16S-23S.
67. Funke K., Eysel U. T. Possible enhancement of GABAergic inputs to cat dorsal lateral geniculate relay cells by serotonin. Neuroreport 1995; 6: 474-476.
68. Yoshida M., Sasa M., Takaori S. Serotonin-mediated inhibition from dorsal raphe neurons nucleus of neurons in dorsal lateral geniculate and thalamic reticular nuclei. Brain Res 1984; 290: 95-105.
69. Vollenweider F. X., Vontobel P., Hell D., Leenders K. L. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man - a PET study with [11C]raclopride. Neuropsychopharmacology 1999; 20: 424-433.
70. Manfridi A., Brambilla D., Mancia M. Stimulation of NMDA and AMPA receptors in the rat nucleus basalis of Meynert affects sleep. Am J Physiol 1999; 277: R1488-1492.
71. Zhelyazkova-Savova M. G., Giovannini G., Pepeu Increase of cortical acetylcholine release after systemic administration of chlorophenylpiperazine in the rat: an in vivo microdialysis study. Neurosci Lett 1997; 236: 151-154.
72. Moller M. Fine structure of pinealopetal innervation of the mammalian pineal gland. Microsc Res Tech 1992; 21: 188-204.
73. Shaji A. V., Kulkarni S. K. Central nervous system depressant activities of melatonin in rats and mice. Indian J Exp Biol 1998; 36: 257-263.
74. Tooley G. A., Armstrong S. M., Norman T. R., Sali A. Acute increases in night-time plasma melatonin levels following a period of meditation. Biol Psychol 2000; 53: 69-78.
75. Dollins A. B., Lynch H. J., Wurtman R. J. et al. Effect of pharmacological daytime doses of melatonin on human mood and performance. Psychopharmacology 1993; 112: 490-496.
76. Monti J. A., Christian S. T. N,N-Dimethyltryptamine: an endogenous hallucinogen. Intern Rev Neurobiol 1981; 22: 83-110.
77. Strassman R. J., Clifford R., Qualls R., Berg L. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltrypamine in humans. Biol Psychiatr 1996; 39: 784-795.
78. Strassan R. J., Clifford R. Dose-response study of N,N-dimethyltrypamine in humans. I: Neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiatr 1994; 51: 85-97.